JOAN VILA FRANCES-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

2022

  1. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  2. MICEmi: A method to identify cognitive endophenotypes of mental illnesses

    European Psychiatry, Vol. 65, Núm. 1

  3. Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders

    Acta Psychiatrica Scandinavica, Vol. 146, Núm. 3, pp. 215-226

  4. Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study

    Journal of Affective Disorders, Vol. 300, pp. 99-108

2020

  1. Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia

    Frontiers in Psychology, Vol. 11

2019

  1. Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study.

    Journal of Affective Disorders, Vol. 257, pp. 31-37

2017

  1. Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study

    Journal of Affective Disorders, Vol. 215, pp. 156-162